Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

TScan Therapeutics, Inc. (TCRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $4.68 Metrics
OS: 47.8 M
Market cap: $224 M
Net cash: $209 M $4.37 per share
EV: $14.9 M

 
TTM Valuation
EBITDA
EBIT ($99.3) M
EPS ($1.44)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19
Revenues13.559.810.145.01.19.4
            Revenue growth33.5%33.1%834.7% -88.5% 
Cost of goods sold0.080.20.058.80.014.2
Gross profit13.5-20.410.1-13.81.1-4.8
            Gross margin100.0%-34.0%100.0%-30.8%100.0%-50.5%
Research and development59.8 45.0 20.6 
General and administrative20.420.413.813.86.74.8
EBIT-66.6-66.6-48.6-48.6-26.2-14.2
            EBIT margin-492.3%-111.4%-479.6%-108.2%-2417.8%-150.5%
Pre-tax income-66.2-66.2-48.6-48.6-26.1-13.7
Income taxes0.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%0.0%
Net income-66.2-66.2-48.6-48.6-26.1-13.7
            Net margin-489.3%-110.7%-479.5%-108.2%-2408.0%-144.7%
 
Diluted EPS($2.75)($2.75)($4.17)($4.17)($28.52)($35.47)
Shares outstanding (diluted)24.024.011.711.70.90.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy